COR Q4 2019 Earnings — Cencora, Inc. Revenue & Financial Results | Market Cap Arena

CORCencora, Inc.

$68B

Q4 2019 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$45.6B+5.4% YoY

Gross Profit

$1.1B2.4% margin

Operating Income

$351M0.8% margin

Net Income

$133M0.3% margin

EPS (Diluted)

$0.63

QoQ Revenue Growth

+0.9%

Cash Flow

Operating Cash Flow

$673M

Free Cash Flow

$593M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$39.2B

Total Liabilities

$36.5B

Stockholders' Equity

$2.9B

Cash & Equivalents

$3.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$45.6B	$43.3B	+5.4%
Gross Profit	$1.1B	$912M	+17.7%
Operating Income	$351M	$254M	+38.1%
Net Income	$133M	$233M	-43.2%

Revenue Segments

Pharmaceutical Distribution

$43.9B96%

Other Segments

$1.8B4%

Geographic Segments

Other Segments

$1.8B100%